These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3255162)

  • 21. [Bactericidal effects of commonly used antiseptics/disinfectants on nosocomial bacterial pathogens and the relationship between antibacterial and biocide resistance].
    Fiçici SE; Durmaz G; Ilhan S; Akgün Y; Köşgeroğlu N
    Mikrobiyol Bul; 2002; 36(3-4):259-69. PubMed ID: 12838659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
    Wroblewska MM; Rudnicka J; Marchel H; Luczak M
    Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo.
    Bergholm AM; Dornbusch K
    J Chemother; 1989 Jul; 1(4 Suppl):64-6. PubMed ID: 16312306
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3616-22. PubMed ID: 11709353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
    J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polynomial regression of the minimum inhibitory concentration--the inhibition halo of 12 disinfectants on various gram-positive and gram-negative microorganisms].
    Herruzo-Cabrera R; Mingo-Leal V; Herreros-Ortega A; Carrasco de la Peña JL; Rey-Calero J
    Agressologie; 1986 May; 27(5):407-11. PubMed ID: 3766894
    [No Abstract]   [Full Text] [Related]  

  • 29. [Influence of serum on the minimal inhibitory concentration, the minimal bacterial concentration and bactericidal rate of various 2d and 3d generation cephalosporins].
    Mattina R; Raimondi A; Bellotti MG
    G Ital Chemioter; 1985; 32(1):229-37. PubMed ID: 3830784
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sensitivity of bacteria to therapeutic drugs (Zurich 1996)].
    Wüst J; Zbinden R; Kayser FH
    Praxis (Bern 1994); 1998 Mar; 87(12):403-12. PubMed ID: 9564237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics".
    Bergan T; Bruun JN; Digranes A; Lingaas E; Melby KK; Sander J
    Scand J Infect Dis Suppl; 1997; 103():1-36. PubMed ID: 9253777
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal activity of subinhibitory concentrations of mezlocillin and azlocillin in blood of patients with chronic lymphatic leukaemia.
    Shah PM; Sponheimer T; Stille W
    J Chemother; 1989 Jul; 1(4 Suppl):1293-4. PubMed ID: 16312871
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
    Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
    Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial pathogens (non-Mycobacterium) from sputum culture and antimicrobial susceptibility.
    Srifuengfung S; Sangsawang M; Komolpis P; Dhiraputra C; Chompanee B
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):96-9. PubMed ID: 9740278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Cobas Bact automated system for susceptibility testing of Enterobacteriaceae, Pseudomonas aeruginosa, and Enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards.
    Heizmann W; Werner H; Heilmann F
    Infection; 1988; 16(1):63-8. PubMed ID: 3129374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.